Unsere Teams

Nach Platform filtern
  • controller
  • controller
  • controller
  • controller
Nach Standort filtern
  • controller
  • controller
  • controller
  • controller

Unsere Teams

Unsere Teams werden durch u.a. unsere Rechtsabteilung unterstützt.

Bart Diels

Bart Diels

Managing Partner - Head Health & Care

Belgien

Bart Diels, Managing Partner - Head Health & Care

During his more than 20 years at Gimv, Bart Diels has built a successful and broad full cycle track record, both in early and late stage investments, in business building, buy & build strategies and exit (IPO & trade sale) and this in different sectors.

Bart guided early stage companies such as BAI, Coreoptics, eXimius, Filepool and Metris from a smart idea towards a rewarding exit. Also later stage deals such as FICS and LMS were successfully sold. Today, Bart is chairman at OTN Systems and board member at Eurocept. In addition to his deal experience, Bart was also very instrumental in building out Gimv’s Venture Capital team and practice. His broad experience will be vital in further expanding Gimv’s Health & Care platform, which he has been leading since the end of 2012.

Bart holds a Master’s degree in Financial and Quantitative Economics and an MBA, both from the University of Antwerp (Belgium).

Kontakt

Karel Oomsstraat 37
2018 Antwerpen

Belgien

Bart Diels
Ruth Bongers

Ruth Bongers

Principal

Niederlande

Ruth Bongers, Principal

Ruth Bongers joined the Gimv Health & Care team in 2015.

Prior to joining Gimv, she worked at KPMG corporate finance, where she focused on companies active within business services and healthcare. As part of the corporate finance team of KPMG, both in the Netherlands and India, Ruth Bongers advised companies and their shareholders on strategic valuations, mergers & acquisitions and related financial analyses.

Ruth Bongers holds a Master’s degree in Business Administration from the Vrije Universiteit (Amsterdam) and Finance & Investments from the Erasmus University (Rotterdam).

Kontakt

+31 70 3 618 605

Berlage-Huis
Groenhovenstraat 2
2596 HT Den Haag

Niederlande

Ruth Bongers
Martijn Bouw

Martijn Bouw

Analyst

Niederlande

Martijn Bouw, Analyst

Martijn studied Financial Economics and Business Economics at Rotterdam University. After an internship at Gimv and Barclays Investment Bank Martijn joined the Dutch team in January 2018 as Business Analyst.

Kontakt

+31 70 3 618 614

Berlage-Huis
Groenhovenstraat 2
2596 HT Den Haag

Niederlande

Martijn Bouw
Benoit Chastaing

Benoit Chastaing

Partner

Frankreich

Benoit Chastaing, Partner

Benoit joined Gimv's Health & Care team in 2016. Before Benoit was Head of M&A and IR at Medipole Partenaires Group (the 3rd largest private healthcare organizations in the territory with 55 care centers). As such, he was member of the Executive Committee of the group. He joined the management team of Medipole Partenaires in 2007. He directed many high level operations for the Group (acquisition, LBO operation, bond financing, etc.). In 2013, Benoit was a leader in one of the largest transactions of the sector (€1.1 billion): the merge of Médi-Partenaires and Medipole Sud Santé to give rise to the third largest health group in France.

Prior to joining Medipole Partenaires, Benoit worked at PwC as an auditor, then joined Rexel where he held several responsibilities both in France and abroad, most recently as Chief Financial Officer of southern Europe.
He graduated from ESCEM and the IMD Lausanne. Former auditor of IHEDN (66th SN), He is also a reservist in the French Navy (Lieutenant Commander).

Kontakt

+33 1 58 36 45 77

83, rue Lauriston
75116 Paris

Frankreich

Benoit Chastaing
Nicolas De Bruyne

Nicolas De Bruyne

Analyst

Belgien

Nicolas De Bruyne, Analyst

Nicolas joined Gimv in March 2017 as multiplatform analyst in Antwerp. He previously worked at ING Corporate Finance in Belgium and New York, where he was active on several buy and sell mandates, mainly within retail and IT.

Nicolas studied Business Engineering at University of Ghent and attained a Master in Financial Management at Vlerick Business School. He also passed level 1 and 2 of the CFA curriculum. 

Kontakt

+32 3 290 21 27

Karel Oomsstraat 37
2018 Antwerpen

Belgien

Nicolas De Bruyne
Katharina Dorsch

Katharina Dorsch

Associate

Deutschland

Katharina Dorsch, Associate

Katharina Dorsch joined Gimv’s Health & Care team as an associate in 2016. She is a physician and graduated from Heidelberg University in 2012 where she did her doctoral thesis in the field of neurooncology. In 2016, Katharina received a Master of Science in Business Administration from the Rotterdam School of Management, Erasmus University. Prior to that, she had been working as a surgeon at the Department of Trauma and Orthopedic Surgery at Klinikum Stuttgart.

Kontakt

+49 89 44 23 275 40

Promenadeplatz 12
80333 München

Deutschland

Katharina Dorsch
Karolien Fieremans

Karolien Fieremans

Senior Financial Analyst

Belgien

Karolien Fieremans, Senior Financial Analyst

Karolien Fieremans joined Gimv in 2010. Before, she worked at EY as Financial Auditor with focus on assurance in the financial services sectors of asset management, banking & capital markets.

Karolien holds a Master in Business Engineering and a Master in Accountancy & Finance, both from the University of Leuven (KU Leuven) as well as an Executive Master in Corporate Finance from the Vlerick Business School.

Kontakt

Karel Oomsstraat 37
2018 Antwerpen

Belgien

Karolien Fieremans
Thomas Harth

Thomas Harth

Analyst

Belgien

Thomas Harth, Analyst

After a six-month internship within Health&Care, Thomas has been appointed Analyst Health&Care in our Antwerp office. 
Thomas has a Master degree in Bioengineering and in Applied Economics, both from the University of Ghent. 
During his studies he focussed on the synthesis of complex organic compounds & early stage supporting models for startups.

Kontakt

+32 3 290 21 44

Karel Oomsstraat 37
2018 Antwerpen

Belgien

Thomas Harth
Elderd Land

Elderd Land

Partner

Niederlande

Elderd Land, Partner

Elderd Land joined Gimv in 2000, investing in the Health & Care and Technology sectors. He is an engaged board member and sparring partner for the entrepreneurs with focus on business building and value creation in the portfolio companies. He holds board seats at Equipe Zorgbedrijven, Eurocept and Oldelft Ultrasound. Previously he managed the investments in a.o. 3mensio Medical Imaging (acquired by Esaote), GreenPeak (acquired by Qorvo) Liquavista (acquired by Samsung), RES Software (acquired by Ivanti), and actively supported other Gimv investments such as Telenet (Euronext) and Option (Euronext).

Prior to joining Gimv, Elderd worked at ABN AMRO Corporate Finance as head of the telecom sector team in Amsterdam, and at KPN Telecom in the International Business Development group. In both roles, he was involved in a wide range of M&A transactions in Europe and Asia.

Elderd holds a Master in Business Administration from the Erasmus University of Rotterdam (the Netherlands).

Kontakt

+31 70 3 618 618

Berlage-Huis
Groenhovenstraat 2
2596 HT Den Haag

Niederlande

Elderd Land
Marie-Justine Lecomte

Marie-Justine Lecomte

Analyst

Frankreich

Marie-Justine Lecomte, Analyst

Marie-Justine Lecomte joined Gimv in 2016 as an analyst multi-platform. Prior to joining Gimv, she worked as an intern in Corporate Finance within the Investment Division of EDF and in M&A at CM-CIC Corporate Advisory.
Marie-Justine graduated from Audencia Business School (Nantes, France).

Kontakt

+33 1 58 36 45 62

83, rue Lauriston
75116 Paris

Frankreich

Marie-Justine Lecomte
Gautier Lefebvre

Gautier Lefebvre

Principal

Frankreich

Gautier Lefebvre, Principal

Before joining the Gimv Health&Care team in 2015, Gautier worked as an Associate in the M&A department at Bank Degroof. Over these 5 years, he advised various midcap M&A transactions, especially within the healthcare industry. He also had experiences at Mazars and GDF Suez.

Gautier graduated from Ecole Centrale de Lyon (France).

Kontakt

+33 1 58 36 45 87

83, rue Lauriston
75116 Paris

Frankreich

Gautier Lefebvre
Karl Nägler

Karl Nägler

Partner

Deutschland

Karl Nägler, Partner

Vor seinem Einstieg bei Gimv im Jahr 2011 war Karl Nägler General Partner bei Ventech, einem Venture Capital Fonds in Paris mit Fokussierung auf Europa und China. Seine Karriere begann er 2002 bei Atlas Venture in London und München.

Karl Nägler kann eine bemerkenswerte Erfolgsbilanz an Investments in früh- und spätphasige Unternehmen im Life Science-Bereich aufweisen. Er war maßgeblich am Aufbau, an der Finanzierung und/oder an Exits zahlreicher Start-ups in Europa beteiligt, darunter U3 Pharma (von Daiichi Sankyo übernommen), Nitec Pharma (von Horizon Pharma übernommen, HZNP:US), Egalet (EGLT:US), Funxional Therapeutics (von Boehringer Ingelheim übernommen) und Themis.

Als Partner bei Gimv hat Karl Nägler die Investitionen in Prosonix (von Circassia übernommen), Covagen (von Johnson & Johnson übernommen, JNJ:US), Biom'up (BUP:EPA), Topas Therapeutics, Breath Therapeutics und Imcheck Therapeutics umgesetzt und Gimv im Aufsichtsrat dieser Unternehmen, wie auch im Aufsichtsrat von Actogenix (von Intrexon übernommen, XON:US) vertreten.

Zuvor war er als wissenschaftlicher Mitarbeiter am CNRS für Neurochemie in Straßburg tätig. Karl Nägler hat am Max-Delbrück-Centrum für Molekulare Medizin in Berlin im Bereich Molekulare Neurobiologie promoviert und erwarb sein Diplom in Biologie an der Freien Universität Berlin.

Kontakt

+49 89 4423 275 50

Promenadeplatz 12
80333 München

Deutschland

Karl Nägler
François-Xavier Rico

François-Xavier Rico

Analyst

Frankreich

François-Xavier Rico, Analyst

François-Xavier Rico joined Gimv in 2017 as a multiplatform analyst in Paris. Prior to joining Gimv, he worked as an intern in M&A at Groupe Crédit Agricole and in Private Equity at Qualium Investissement.

François-Xavier graduated with a master in Corporate Finance and Financial Engineering (225) from Paris-Dauphine University.

Kontakt

+33 1 58 36 45 72

83, rue Lauriston
75116 Paris

Frankreich

François-Xavier Rico
Patrick Van Beneden

Patrick Van Beneden

Partner

Belgien

Patrick Van Beneden, Partner

Patrick Van Beneden joined Gimv in 1985 and has built a successful track record in life sciences, both in early and late stage investments and exits (Devgen, CropDesign, Plexxikon, Endosense,…).

He is currently representing Gimv on the boards of JenaValve, Complix, AgroSavfe, G-Therapeutics and FlandersBio and holds an observer seat at EndoStim. Former board seats include Innogenetics, Crucell, Hypnion (acquired by Eli Lilly), CropDesign (acquired by BASF), Astex and Ablynx.

Patrick has a degree in financial sciences from Vlekho in Brussels.

Kontakt

+32 3 290 21 36

Karel Oomsstraat 37
2018 Antwerpen

Belgien

Patrick Van Beneden
Hidde Van Kerckhoven

Hidde Van Kerckhoven

Associate

Belgien

Hidde Van Kerckhoven, Associate

Hidde joined Gimv's Health & Care team in 2016. Since 2013 he has been active as an Associate in the Brussels office of Riverside, a global private equity group with a strong activity in H&C (around 25 H&C deals in their current portfolio). Before that he was an Associate at Zanders, a Dutch corporate finance boutique.

Hidde holds a MSc in financial management.

Kontakt

+32 3 290 21 49

Karel Oomsstraat 37
2018 Antwerpen

Belgien

Hidde Van Kerckhoven
Roland Veldhuijzen van Zanten

Roland Veldhuijzen van Zanten

Associate

Niederlande

Roland Veldhuijzen van Zanten, Associate

Roland Veldhuijzen van Zanten joined Gimv as a multiplatform associate in 2017, based in The Hague.

Prior to joining Gimv, Roland worked at Credit Suisse as a member of the EMEA Consumer & Retail team in London, where he advised on M&A, IPO and financing transactions. Prior to Credit Suisse, Roland completed internships at Heineken (Congo) and Air France KLM (Argentina).

Roland holds a MSc. in Financial Economics from the Erasmus School of Economics (Rotterdam) and a BSc. in International Business Administration from the VU University (Amsterdam) in the Netherlands.

Kontakt

+31 70 3 618 604

Berlage-Huis
Groenhovenstraat 2
2596 HT Den Haag

Niederlande

Roland Veldhuijzen van Zanten
Maximilian von den Hoff

Maximilian von den Hoff

Analyst

Deutschland

Maximilian von den Hoff, Analyst

Maximilian von den Hoff ist seit 2017 als Multiplatform-Analyst bei Gimv tätig.

Vor seiner Tätigkeit bei Gimv war Maximilian im Investment Banking Department bei Morgan Stanley in Frankfurt beschäftigt. Während dieser Zeit arbeitete Maximilian an verschiedenen Verkaufsmandaten und Kapitalmarkttransaktionen.

Maximilian besitzt einen Abschluss, MSc. in Accounting & Finance von der London School of Economics, sowie einen BSc. in General Management von der EBS Universität für Wirtschaft und Recht (Oestrich-Winkel) in Deutschland.

Kontakt

+49 89 44 23 275 20

Promenadeplatz 12
80333 München

Deutschland

Maximilian von den Hoff
Michaël Vlemmix

Michaël Vlemmix

Associate

Belgien

Michaël Vlemmix, Associate

Michaël Vlemmix is a Bio-Engineer (Biotechnology) holding a Master in Management from the Antwerp Management School. He started his professional career at a medical device spin-off of the University of Antwerp.In February 2016, he switched to investment banking at KBC Securities as a Biotech/Healthcare analyst where he worked on initial public offerings and several other capital market transactions while providing coverage of the Benelux Biotech & Healthcare stocks.

Late 2017, he joined Gimv as an Associate Health & Care.

Kontakt

+32 290 21 77

Karel Oomsstraat 37
2018 Antwerpen

Belgien

Michaël Vlemmix
Philipp von Hammerstein

Philipp von Hammerstein

Partner

Deutschland

Philipp von Hammerstein, Partner

Philipp v. Hammerstein ist dem Gimv Health & Care team 2016 beigetreten.

Zuvor hat er bei KPMG in Deutschland gearbeitet, wo er im Bereich Deal Advisory – M&A tätig war. Dort hat er über 50 Projekte begleitet, wobei er sich insbesondere auf die Beratung von Transaktionen und strategischen Fragestellungen im Gesundheitswesen (Healthcare und Life-Sciences) fokussiert hat. Unterschiedlichste Mandantengruppen, wie große börsennotierte Konzerne (bspw. DAX, MDAX), Familienunternehmen und die öffentliche Hand aber insbesondere auch Private Equity Fonds bzw. ihre Portfoliounternehmen wurden von ihm betreut.

Philipp v. Hammerstein hat in Bonn, Berlin und Toulouse (Frankreich) studiert. Er ist Diplomkaufmann (Technische Universität Berlin) und besitzt einen Master in Management (ESC Toulouse/Toulouse Business School).

Kontakt

+49 89 44 23 275 10

Promenadeplatz 12
80333 München

Deutschland

Philipp von Hammerstein